This would agree with our previous results showing ESC signatures in the mouse skin carcinomas [12], with findings showing that tumour aggressiveness is predicted by these ESC GE profiles [36], and with the presence of such profiles in p53-mutant human BC tumours [14]. This evidence concerns the gene TP53 and neoplasm.